Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the header and footer still visible. This replaces the previous study content and signals restricted access to the page.
    Difference
    21%
    Check dated 2026-09-20T00:25:13.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new publication citation has been added under Publications, referencing a Blood Neoplasia article on favezelimab plus pembrolizumab in anti-PD-1-refractory classic Hodgkin lymphoma. This addition provides additional literature context for the study record without altering the study's design, eligibility criteria, or reported results.
    Difference
    0.0%
    Check dated 2026-09-12T23:38:10.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now includes NIH grant/contract references for 2023 and 2018, indicating funding sources, and the revision history shows an update to Revision: v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:54.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a generic error screen indicating the requested record is unavailable, replacing the usual study details with an error notice.
    Difference
    19%
    Check dated 2026-08-08T18:15:00.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The study record shows the status updated to Terminated on 2026-07-28 with a Business Reason indicating no longer looking for participants, replacing the prior Completed status.
    Difference
    0.2%
    Check dated 2026-08-01T14:12:55.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4. This reflects a new entry in the study page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T10:16:48.000Z thumbnail image

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.